Contributi in atti di convegno, riviste e volumi

Basso U.; Procopio G.; Fornarini G.; Massari F.; Bearz A.; Fratino L.; Milella M.; Bassanelli M.; Ermacora P.; Bimbatti D.; Verzoni E.; Rizzo M.; Porta C., Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16), «ONCOLOGY», 2021, 99, pp. 747 - 755 [Articolo in rivista]

Mollica, V; Rizzo, A; Massari, F, Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2021, 385, pp. 956 - 957 [Articolo in rivista]

Santoni M.; Piva F.; Porta C.; Bracarda S.; Heng D.Y.; Matrana M.R.; Grande E.; Mollica V.; Aurilio G.; Rizzo M.; Giulietti M.; Montironi R.; Massari F., Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 84 - 92 [Articolo in rivista]

Aurilio G.; Cimadamore A.; Lopez-Beltran A.; Scarpelli M.; Massari F.; Verri E.; Cheng L.; Santoni M.; Montironi R., Narrative review: Update on immunotherapy and pathological features in patients with bladder cancer, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1521 - 1529 [Articolo in rivista] Open Access

de Velasco G.; Ruiz-Granados A.; Reig O.; Massari F.; Climent Duran M.A.; Verzoni E.; Graham J.; Llarena R.; De Tursi M.; Donskov F.; Iglesias C.; Pandha H.S.; Garcia del Muro X.; Procopio G.; Oudard S.; Castellano D.; Albiges L., Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib, «BJU INTERNATIONAL», 2021, 128, pp. 254 - 261 [Articolo in rivista]

Mollica V.; Marchetti A.; Rosellini M.; Nuvola G.; Rizzo A.; Santoni M.; Cimadamore A.; Montironi R.; Massari F., An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 1 - 20 [Articolo in rivista] Open Access

Bersanelli M.; Buti S.; Rizzo M.; Cortellini A.; Cattrini C.; Massari F.; Masini C.; Vitale M.G.; Fornarini G.; Caffo O.; Atzori F.; Gatti A.; Macrini S.; Mucciarini C.; Galli L.; Morelli F.; Stellato M.; Fanelli M.; Corti F.; Zucali P.A.; Toscani I.; Dalla Volta A.; Gernone A.; Baldessari C.; La Torre L.; Zara D.; Gennari A.; Bracarda S.; Procopio G.; Porta C., GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak, «THERAPEUTIC ADVANCES IN UROLOGY», 2021, 13, pp. 1 - 6 [Articolo in rivista] Open Access

Rizzo A.; Mollica V.; Massari F., Randomized Clinical Trials in the Era of Precision Oncology - The Role of End Points, Industry Funding, and Medical Writing Integrity, «JAMA ONCOLOGY», 2021, 7, pp. 1577 - 1577 [Articolo in rivista]

Rizzo A.; Mollica V.; Santoni M.; Massari F., Cancer immunotherapy: Current and future perspectives on a therapeutic revolution, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, pp. 1 - 3 [Articolo in rivista] Open Access

Rizzo A.; Mollica V.; Massari F., Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer, «JAMA ONCOLOGY», 2021, 7, pp. 1068 - 1068 [Articolo in rivista]

Rizzo A.; Santoni M.; Mollica V.; Logullo F.; Rosellini M.; Marchetti A.; Faloppi L.; Battelli N.; Massari F., Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2021, 17, pp. 1455 - 1466 [Articolo in rivista]

Santoni M.; Massari F.; Montironi R.; Battelli N., Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages, «BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER», 2021, 1876, pp. 188547 - 188551 [Articolo in rivista]

Santoni M.; Miccini F.; Cimadamore A.; Piva F.; Massari F.; Cheng L.; Lopez-Beltran A.; Montironi R.; Battelli N., An update on investigational therapies that target STAT3 for the treatment of cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 245 - 251 [Articolo in rivista]

Rizzo A.; Rosellini M.; Marchetti A.; Mollica V.; Massari F., Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: A critical overview of recent evidence, «IMMUNOTHERAPY», 2021, 13, pp. 685 - 692 [Articolo in rivista]

Marchetti A.; Rosellini M.; Rizzo A.; Mollica V.; Battelli N.; Massari F.; Santoni M., An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma, «EXPERT OPINION ON PHARMACOTHERAPY», 2021, 22, pp. 2323 - 2336 [Articolo in rivista]

Massari F.; Rizzo A.; Mollica V.; Santoni M., A brand-new CAR for macrophages: Is it time to fire up the engines of a new era for the treatment of renal cell carcinoma?, «FUTURE ONCOLOGY», 2021, 17, pp. 1839 - 1841 [Articolo in rivista]

Rizzo A.; Mollica V.; Santoni M.; Massari F., Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 1225 - 1232 [Articolo in rivista]

Cimadamore A.; Cheng L.; Massari F.; Santoni M.; Pepi L.; Franzese C.; Scarpelli M.; Lopez-Beltran A.; Galosi A.B.; Montironi R., Circulating tumor dna testing for homology recombination repair genes in prostate cancer: From the lab to the clinic, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 1 - 15 [Articolo in rivista] Open Access

Santoni M.; Cimadamore A.; Massari F.; Sorgentoni G.; Cheng L.; Lopez-Beltran A.; Battelli N.; Montironi R., Narrative review: Predicting future molecular and clinical profiles of prostate cancer in the United States, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1562 - 1568 [Articolo in rivista] Open Access

Cimadamore A.; Cheng L.; Scarpelli M.; Lopez-Beltran A.; Mollica V.; Montironi R.; Massari F., Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation, «EUROPEAN UROLOGY», 2021, 79, pp. 17 - 19 [Articolo in rivista]